There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on AMN Healthcare Services (AMN – Research Report), Eli Lilly & Co (LLY – Research Report) and Sarepta Therapeutics (SRPT – Research Report) with bullish sentiments.
AMN Healthcare Services (AMN)
BMO Capital analyst Jeffrey Silber maintained a Buy rating on AMN Healthcare Services on February 16 and set a price target of $83.00. The company’s shares closed last Friday at $61.69, close to its 52-week low of $57.80.
Silber has an average return of
According to TipRanks.com, Silber is ranked #182 out of 8727 analysts.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for AMN Healthcare Services with a $81.40 average price target, representing a 21.4% upside. In a report issued on February 15, JMP Securities also maintained a Buy rating on the stock with a $87.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Eli Lilly & Co (LLY)
In a report issued on February 16, Evan Seigerman from BMO Capital maintained a Buy rating on Eli Lilly & Co, with a price target of $865.00. The company’s shares closed last Friday at $782.06, close to its 52-week high of $794.47.
According to TipRanks.com, Seigerman is a 4-star analyst with an average return of
Eli Lilly & Co has an analyst consensus of Strong Buy, with a price target consensus of $787.17, a 2.1% upside from current levels. In a report issued on February 1, Cantor Fitzgerald also maintained a Buy rating on the stock with a $630.00 price target.
Sarepta Therapeutics (SRPT)
In a report issued on February 16, Kostas Biliouris from BMO Capital maintained a Buy rating on Sarepta Therapeutics, with a price target of $170.00. The company’s shares closed last Friday at $134.61.
According to TipRanks.com, Biliouris is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Sarepta Therapeutics with a $164.42 average price target, implying a 17.4% upside from current levels. In a report issued on February 1, Bank of America Securities also maintained a Buy rating on the stock with a $164.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on AMN:
